PDS Biotechnology Reports Q1 2026 Financial Results

PDS Biotechnology announced its first-quarter financial results for 2026, reporting a net loss of $7.3 million. The company has made its complete earnings call transcript available, offering detailed insights into its performance and strategic discussions. Benzinga APIs provide access to real-time financial data and earnings call transcripts, enabling developers and investors to integrate this information into their platforms. Further details and the full transcript can be accessed through provided links.